Drug Profile
AKP 007
Alternative Names: AKP-007Latest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator ASKA Pharmaceutical
- Class Antiulcers; Pyrazoles
- Mechanism of Action Gastrointestinal hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Endocrine disorders; Gastrointestinal disorders
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for phase-I development in Endocrine-disorders in Japan
- 28 Jan 2018 No recent reports of development identified for phase-I development in Gastrointestinal-disorders in Japan
- 31 Dec 2014 Phase-I clinical trials in Endocrine disorders in Japan (unspecified route) prior to December 2014